Is Shanrong Biotechnology Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Shanrong Biotechnology Corp (SRBT) is currently classified as NOT HALAL as of February 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Shanrong Biotechnology Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Shanrong Biotechnology Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Shanrong Biotechnology Corp?

Muslim investors may consider investing in Shanrong Biotechnology Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Shanrong Biotechnology Corp classified as NOT HALAL?

Musaffa determines the Shariah status of Shanrong Biotechnology Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Shanrong Biotechnology Corp updated?

The Shariah compliance status of Shanrong Biotechnology Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Shanrong Biotechnology Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Shanrong Biotechnology Corp?

You can check the latest Shariah compliance status of Shanrong Biotechnology Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

SRBT Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: February 04, 2025

Report Source: 2024 3rd Quarter Report

Shanrong Biotechnology Corp. Stock Analysis SRBT

United States Industrials Nano Cap Report: Q3, 2024

Shanrong Biotechnology Corp. operates as a shell company. The company is headquartered in Exton, Pennsylvania and currently employs 3 full-time employees. The company went IPO on 2008-12-01. The firm owns and operates three patents: Long-lasting preparation of long-term stable intravenous melatonin injectable addressing sepsis, bacterial pathologies, and other inflammatory pathology; new melatonin formulations for the treatment of chemotherapy-resistant tumors addressing cancer (head and neck, prostate, breast, ovarian, melanoma), and injectable melatonin composition for the treatment of viral diseases addressing coronavirus disease of 2019 (COVID-19) and other viral diseases.

Key Statistics of Shanrong Biotechnology Corp (SRBT)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.00$0.00

Today's Open

$0.00

Volume

650.00

P/E Ratio (TTM)

52 Week Range

$0.00$0.50

Market Cap

100.00K

Avg. Volume